TW202321437A - 青少年左心發育不全症候群治療中間質幹細胞的用途 - Google Patents

青少年左心發育不全症候群治療中間質幹細胞的用途 Download PDF

Info

Publication number
TW202321437A
TW202321437A TW111127940A TW111127940A TW202321437A TW 202321437 A TW202321437 A TW 202321437A TW 111127940 A TW111127940 A TW 111127940A TW 111127940 A TW111127940 A TW 111127940A TW 202321437 A TW202321437 A TW 202321437A
Authority
TW
Taiwan
Prior art keywords
patient
stem cells
mesenchymal stem
need
left heart
Prior art date
Application number
TW111127940A
Other languages
English (en)
Chinese (zh)
Inventor
約書亞 M 哈爾
桑賈伊 考沙爾
Original Assignee
美商生命科學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商生命科學股份有限公司 filed Critical 美商生命科學股份有限公司
Publication of TW202321437A publication Critical patent/TW202321437A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/029—Measuring blood output from the heart, e.g. minute volume
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW111127940A 2021-07-26 2022-07-26 青少年左心發育不全症候群治療中間質幹細胞的用途 TW202321437A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163203519P 2021-07-26 2021-07-26
US63/203,519 2021-07-26

Publications (1)

Publication Number Publication Date
TW202321437A true TW202321437A (zh) 2023-06-01

Family

ID=83049982

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111127940A TW202321437A (zh) 2021-07-26 2022-07-26 青少年左心發育不全症候群治療中間質幹細胞的用途

Country Status (9)

Country Link
US (1) US20240350549A1 (cg-RX-API-DMAC7.html)
EP (1) EP4376950A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527034A (cg-RX-API-DMAC7.html)
KR (1) KR20240040776A (cg-RX-API-DMAC7.html)
CN (1) CN117999082A (cg-RX-API-DMAC7.html)
AU (1) AU2022316959A1 (cg-RX-API-DMAC7.html)
CA (1) CA3227475A1 (cg-RX-API-DMAC7.html)
TW (1) TW202321437A (cg-RX-API-DMAC7.html)
WO (1) WO2023009537A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025062365A1 (en) * 2023-09-22 2025-03-27 Mesoblast International Sárl Mesenchymal lineage precursor or stem cells (mlpscs) for use in methods of treating congenital heart disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201806587RA (en) 2016-02-04 2018-09-27 Longeveron Llc Mesenchymal stem cells as vaccine adjuvants and methods for using the same
TW201831681A (zh) 2016-11-11 2018-09-01 美商生命科學公司 使用人類間葉幹細胞以實現細胞性及體液性免疫的方法
US12496316B2 (en) 2017-06-19 2025-12-16 Longeveron Inc. Treatment of sexual dysfunction and improvement in sexual quality of life
MX2022003593A (es) * 2019-09-24 2022-09-19 Mezzion Pharma Co Ltd Métodos para mejorar el rendimiento del ejercicio, el rendimiento ventricular único y el índice de rendimiento del miocardio (mpi) en la enfermedad cardiaca del ventrículo único, utilizando composiciones de udenafil.

Also Published As

Publication number Publication date
CA3227475A1 (en) 2023-02-02
KR20240040776A (ko) 2024-03-28
US20240350549A1 (en) 2024-10-24
JP2024527034A (ja) 2024-07-19
EP4376950A1 (en) 2024-06-05
CN117999082A (zh) 2024-05-07
AU2022316959A1 (en) 2024-02-29
WO2023009537A1 (en) 2023-02-02

Similar Documents

Publication Publication Date Title
Rupp et al. Intracoronary bone marrow cell application for terminal heart failure in children
Poirier et al. Modified Norwood procedure with a high-flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction
Leśniak-Sobelga et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases—maternal and fetal outcome
Tarui et al. Stem cell therapies in patients with single ventricle physiology
Kianzad et al. Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function, and exercise capacity in chronic thromboembolic pulmonary hypertension
Demir et al. Diagnosis, treatment and outcomes of patients with aortopulmonary window
Castaldi et al. Feasibility, safety, and efficacy of the atrial flow regulator in pediatric patients: a single-center experience
Weale et al. Adult congenital heart disease
US20240350549A1 (en) Use of Mesenchymal Stem Cells in Treatment of Juvenile Hypoplastic Left Heart Syndrome
Haller et al. Surgical strategies in single ventricle management of neonates and infants
HK40103434A (zh) 间充质干细胞在治疗青少年左心发育不良综合征中的用途
Wehman et al. Stem cell therapy for CHD: towards translation
Oka et al. Percutaneous atrial septal defect closure in adult Ebstein's anomaly with exertional hypoxemia
Dodge‐Khatami et al. Tetralogy of fallot
Xu et al. Simultaneous transcatheter treatment of perimembranous ventricular septal defect and other congenital cardiopathies
Holst et al. From safety to benefit in cell delivery during surgical repair of Ebstein anomaly: initial results
Karatza et al. Left ventricular non-compaction in a child with bicuspid aortic valve and aortic coarctation
Tekin Giant left atrial myxoma presenting with cough-syncope syndrome
Selvan et al. Long-term follow-up of persistent truncus arteriosus: Kuwait experience
Juan et al. Two cases of anomalous origin of left coronary artery from the pulmonary artery
Pawliczak et al. Adults with uncorrected tetralogy of Fallot, anomalous coronary artery origin, left ventricular non-compaction, atrial septal defect and recurrent right ventricular outflow tract stenosis
Weale et al. Adult congenital heart disease
Qiu et al. Congenital atresia of the left main coronary artery with left ventricular noncompaction: From infancy to adulthood
Skorek et al. Periprocedural challenges in percutaneous implantation of a self-expanding valve in large pulmonary outflow tracts: Early single-center experiences
Imanov et al. Short-Term and Long-Term Outcomes of Endovascular Versus Surgical Palliation Procedures for Pulmonary Artery Atresia With Intact Ventricular Septum